China Regenerative Medicine International Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was HKD 47.971 million compared to HKD 72.952 million a year ago. Net loss was HKD 404.641 million compared to HKD 1,193.501 million a year ago. Basic loss per share was HKD 0.46 compared to HKD 1.357 a year ago.